The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Over-The-Counter (OTC) Drugs market was valued at US$ 1690.1 million in 2023 and is anticipated to reach US$ 2642.7 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Over-The-Counter (OTC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-The-Counter (OTC) Drugs.
Report Scope
The Over-The-Counter (OTC) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Over-The-Counter (OTC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Over-The-Counter (OTC) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company(Partial List)
- Bayer
- Boehringer Ingelheim
- GSK
- Novartis
- Pfizer
- PGT healthcare
- Sanofi
- Teva Pharmaceuticals
- Takeda
- Cipla
- Sun Pharmaceutical Industries
- Glenmark
- Innovus Pharmaceuticals
Segment by Type
- Cold and Flu Products
- Analgesics
- Dermatological Products
- Gastrointestinal Products
- Vitamin
- Other
Segment by Sale Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Over-The-Counter (OTC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Over-The-Counter (OTC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Over-The-Counter (OTC) Drugs Market Overview
1.1 Product Overview and Scope of Over-The-Counter (OTC) Drugs
1.2 Over-The-Counter (OTC) Drugs Segment by Type
1.2.1 Global Over-The-Counter (OTC) Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Cold and Flu Products
1.2.3 Analgesics
1.2.4 Dermatological Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamin
1.2.7 Other
1.3 Over-The-Counter (OTC) Drugs Segment by Sale Channel
1.3.1 Global Over-The-Counter (OTC) Drugs Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Over-The-Counter (OTC) Drugs Market Size Estimates and Forecasts
1.4.1 Global Over-The-Counter (OTC) Drugs Revenue 2019-2030
1.4.2 Global Over-The-Counter (OTC) Drugs Sales 2019-2030
1.4.3 Global Over-The-Counter (OTC) Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Over-The-Counter (OTC) Drugs Market Competition by Manufacturers
2.1 Global Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Over-The-Counter (OTC) Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Over-The-Counter (OTC) Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Over-The-Counter (OTC) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Over-The-Counter (OTC) Drugs, Product Type & Application
2.7 Over-The-Counter (OTC) Drugs Market Competitive Situation and Trends
2.7.1 Over-The-Counter (OTC) Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Over-The-Counter (OTC) Drugs Players Market Share by Revenue
2.7.3 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Over-The-Counter (OTC) Drugs Retrospective Market Scenario by Region
3.1 Global Over-The-Counter (OTC) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Over-The-Counter (OTC) Drugs Global Over-The-Counter (OTC) Drugs Sales by Region: 2019-2030
3.2.1 Global Over-The-Counter (OTC) Drugs Sales by Region: 2019-2024
3.2.2 Global Over-The-Counter (OTC) Drugs Sales by Region: 2025-2030
3.3 Global Over-The-Counter (OTC) Drugs Global Over-The-Counter (OTC) Drugs Revenue by Region: 2019-2030
3.3.1 Global Over-The-Counter (OTC) Drugs Revenue by Region: 2019-2024
3.3.2 Global Over-The-Counter (OTC) Drugs Revenue by Region: 2025-2030
3.4 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.4.1 North America Over-The-Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Over-The-Counter (OTC) Drugs Sales by Country (2019-2030)
3.4.3 North America Over-The-Counter (OTC) Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.5.1 Europe Over-The-Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Over-The-Counter (OTC) Drugs Sales by Country (2019-2030)
3.5.3 Europe Over-The-Counter (OTC) Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Over-The-Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.7.1 Latin America Over-The-Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Over-The-Counter (OTC) Drugs Sales by Country (2019-2030)
3.7.3 Latin America Over-The-Counter (OTC) Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2019-2030)
4.1.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2019-2024)
4.1.2 Global Over-The-Counter (OTC) Drugs Sales by Type (2025-2030)
4.1.3 Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2019-2030)
4.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2019-2030)
4.2.1 Global Over-The-Counter (OTC) Drugs Revenue by Type (2019-2024)
4.2.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2025-2030)
4.2.3 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Over-The-Counter (OTC) Drugs Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2019-2030)
5.1.1 Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2019-2024)
5.1.2 Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2025-2030)
5.1.3 Global Over-The-Counter (OTC) Drugs Sales Market Share by Sale Channel (2019-2030)
5.2 Global Over-The-Counter (OTC) Drugs Revenue by Sale Channel (2019-2030)
5.2.1 Global Over-The-Counter (OTC) Drugs Revenue by Sale Channel (2019-2024)
5.2.2 Global Over-The-Counter (OTC) Drugs Revenue by Sale Channel (2025-2030)
5.2.3 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Over-The-Counter (OTC) Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Over-The-Counter (OTC) Drugs Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Over-The-Counter (OTC) Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Over-The-Counter (OTC) Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 PGT healthcare
6.6.1 PGT healthcare Corporation Information
6.6.2 PGT healthcare Description and Business Overview
6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Product Portfolio
6.6.5 PGT healthcare Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Over-The-Counter (OTC) Drugs Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Teva Pharmaceuticals
6.8.1 Teva Pharmaceuticals Corporation Information
6.8.2 Teva Pharmaceuticals Description and Business Overview
6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio
6.8.5 Teva Pharmaceuticals Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Corporation Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Takeda Over-The-Counter (OTC) Drugs Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Over-The-Counter (OTC) Drugs Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 Glenmark
6.12.1 Glenmark Corporation Information
6.12.2 Glenmark Over-The-Counter (OTC) Drugs Description and Business Overview
6.12.3 Glenmark Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Glenmark Over-The-Counter (OTC) Drugs Product Portfolio
6.12.5 Glenmark Recent Developments/Updates
6.13 Innovus Pharmaceuticals
6.13.1 Innovus Pharmaceuticals Corporation Information
6.13.2 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Description and Business Overview
6.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio
6.13.5 Innovus Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Over-The-Counter (OTC) Drugs Industry Chain Analysis
7.2 Over-The-Counter (OTC) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Over-The-Counter (OTC) Drugs Production Mode & Process
7.4 Over-The-Counter (OTC) Drugs Sales and Marketing
7.4.1 Over-The-Counter (OTC) Drugs Sales Channels
7.4.2 Over-The-Counter (OTC) Drugs Distributors
7.5 Over-The-Counter (OTC) Drugs Customers
8 Over-The-Counter (OTC) Drugs Market Dynamics
8.1 Over-The-Counter (OTC) Drugs Industry Trends
8.2 Over-The-Counter (OTC) Drugs Market Drivers
8.3 Over-The-Counter (OTC) Drugs Market Challenges
8.4 Over-The-Counter (OTC) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
